Jump to navigation

Home

Sabin

  • About Us
  • Donate
  • Careers
  • Facebook
  • Twitter
  • Google Plus

Search form

  • Our Mission
    • How We Help
    • How We Measure Success
  • Our Experts
    • Sabin Gold Medal Award
  • Our Programs
    • Global Network
    • Vaccine Advocacy & Education
    • Vaccine Development
  • Updates
    • Blog
    • News
    • Events
    • Press Releases
  • Donate
  • Ways to give

You are here

  1. Home ›
  2. Our Programs ›
  3. Vaccine Advocacy & Education ›
  4. SIF ›

Legislation

Our Programs

  • Global Network
    • About NTDs
    • Our Work
    • Why a Network?
    • Join END7
  • Vaccine Advocacy & Education
  • Vaccine Development
    • What We Do
      • Capabilities
      • Partners
    • Human Hookworm Vaccine
      • Project Status
      • History
      • About hookworm
    • Schistosomiasis Vaccine
      • Project Status
      • History
      • About Schistosomiasis
    • Chagas Disease/Leishmaniasis
      • Chagas disease vaccine
      • About Chagas disease
      • About Leishmaniasis
    • SARS Vaccine
      • Project Status
      • About SARS

Even at US$40-50 per child, immunization is still one of public health’s “best buys.”

Languages

  • English English
  • Français Français

Related Updates

Progress for Sustainable Immunization Financing

Read more

Unsung Vaccine Heroes

Read more

Related Events

First Sabin Vaccine Institute Colloquium on Sustainable Immunization Financing (SIF)

03.28.11 to 03.29.11
View event +

  • Our Mission
    • How We Help
    • How We Measure Success
  • Our Experts
    • Sabin Gold Medal Award
  • Our Programs
    • Global Network
    • Vaccine Advocacy & Education
    • Vaccine Development
  • Updates
    • Blog
    • News
    • Events
    • Press Releases

Charity Navigatior, Four Star Charity

Footer Menu

  • Careers
  • Donate
  • Privacy Policy
  • Contact Us
  • Facebook
  • Twitter

© 2012 • Sabin Vaccine Institute • 2000 Pennsylvania Ave, NW, Suite 7100 • Washington, DC 20006 • t. (202) 842-5025